Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions
Huqiao Luo, Vilma Urbonaviciute, Amir Ata Saei, Hezheng Lyu, Massimiliano Gaetani, Ákos Végvári, Yanpeng Li, Roman A. Zubarev, Rikard Holmdahl
Huqiao Luo, Vilma Urbonaviciute, Amir Ata Saei, Hezheng Lyu, Massimiliano Gaetani, Ákos Végvári, Yanpeng Li, Roman A. Zubarev, Rikard Holmdahl
View: Text | PDF
Research Article

NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions

  • Text
  • PDF
Abstract

Low capacity to produce ROS because of mutations in neutrophil cytosolic factor 1 (NCF1/p47phox), a component of NADPH oxidase 2 (NOX2) complex, is strongly associated with systemic lupus erythematosus in both humans and mouse models. Here, we aimed to identify the key immune cell type(s) and cellular mechanisms driving lupus pathogenesis under the condition of NCF1-dependent ROS deficiency. Using cell-specific Cre-deleter, human NCF1-339 variant knockin, and transgenic mouse strains, we show that low ROS production in plasmacytoid dendritic cells (pDCs) exacerbated both pristane-induced lupus and a potentially new Y-linked autoimmune accelerating locus–related spontaneous model by promoting pDC accumulation in multiple organs during lupus development, accompanied by elevated IFN-α levels and expression of IFN-stimulated genes. Mechanistic studies revealed that ROS deficiency enhanced pDC generation through the AKT/mTOR pathway and CCR2-mediated migration to tissues, which together with hyperactivation of the redox-sensitive stimulator of interferon genes/IFN-α/JAK1/STAT1 cascade further augmented type I IFN responses. More importantly, by suppressing these pathways, restoration of NOX2-derived ROS specifically in pDCs protected against lupus. These discoveries explain the causative effect of dysfunctional NCF1 in lupus and demonstrate the protective role of pDC-derived ROS in disease development driven by NCF1-dependent ROS deficiency.

Authors

Huqiao Luo, Vilma Urbonaviciute, Amir Ata Saei, Hezheng Lyu, Massimiliano Gaetani, Ákos Végvári, Yanpeng Li, Roman A. Zubarev, Rikard Holmdahl

×

Figure 7

Generation of pDCs is enhanced via AKT/mTOR pathway in ROS-deficient mice.

Options: View larger image (or click on image) Download as PowerPoint
Generation of pDCs is enhanced via AKT/mTOR pathway in ROS-deficient mic...
(A) Frequency and numbers of pre-pDCs within BM from B10.Q and B10.Q.Ncf1R90/90H (n = 6) at day 3 after pristane injection. (B and C) Monarch mammalian phenotype enrichment analysis of (B) proteomic expression profile and (C) PISA of BM-derived pDCs from B10.Q and B10.Q.Ncf1m1j/m1j mice upon 20-hour stimulation by IFN-α. (D) Protein-protein interaction networks (STRING) of the matching proteins in the PISA data set that are relevant to “abnormal hematopoietic system morphology/development” in Mammalian Phenotype Ontology. The proteins related to “PI3K-Akt-mTOR signaling pathway” in WikiPathways are illustrated in red. (E) Expression of p-AKTThr308 and p-mTORSer2448 in BM SiglecH+ cells from B10.Q and B10.Q.Ncf1m1j/m1j mice upon 15-minute stimulation by imiquimod. The densitometric ratio of the phosphorylated protein to the total protein is calculated. (F) Expression of p-AKTThr308 and p-mTORSer2448 in splenocytes from B10.Q and B10.Q.Ncf1R90/90H with or without GSK2795039 or H2O2 upon 15-minute stimulation by imiquimod. Quantification of bands normalized to cyclophilin A is presented. (G) Expression of CCR2 in BM pDCs from naive B10.Q (n = 5), naive B10.Q.Ncf1R90/90H (n = 6), pristane-treated B10.Q (n = 4), and pristane-treated B10.Q.Ncf1R90/90H (n = 5) mice at day 3 after pristane injection. Statistical analysis is done by 2-tailed Mann-Whitney U test (A, E, and G) and 2-tailed Student’s t test (B and C). *P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts